Barbara Ensoli, MD

Quick facts

Marketed products

• Tat · Immunology / Infectious Disease
  Tat is a therapeutic vaccine based on the HIV Tat protein designed to boost immune responses against HIV-infected cells.

Phase 2 pipeline

• Tat protein

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Barbara Ensoli, MD portfolio CI brief
• Barbara Ensoli, MD pipeline updates RSS

Frequently asked questions about Barbara Ensoli, MD

Related

• Tat · Immunology / Infectious Disease
• Sector hub: All tracked pharma companies